Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition

US10086090B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10086090-B2
Application numberUS-201715438047-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2017
Priority dateJan 28, 2010
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention aims at providing a novel indocyanine compound solving problems of conventionally used indocyanine green, such as solubility in water or physiological saline, a synthesis method and a purification method thereof, and a diagnostic composition including the novel indocyanine compound. Further, provided are a method for evaluating biokinetics of the novel indocyanine compound and a device for measuring biokinetics, and a method and a device for visualizing circulation of fluid such as blood in a living body, which utilize the diagnostic composition. Also, found are a novel indocyanine compound in which a hydrophobic moiety in a near-infrared fluorescent indocyanine molecule is included in a cavity of a cyclic sugar chain cyclodextrin to cover the hydrophobic moiety in the indocyanine molecule with the glucose, and a synthesis method and a purification method thereof. Furthermore, found are a method for fluorescence-imaging an organ other than liver by intravenous administration, a method for evaluating biokinetics of the novel indocyanine compound, a device for measuring biokinetics, and a method and a device for visualizing circulation of fluid such as blood in a living body, utilizing the diagnostic composition including the novel indocyanine compound.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cyclodextrin-bonded indocyanine cation of formula (15), (16), (19) or (20): wherein in the formulas (16) and (20), the indocyanine structure has at least a portion of a naphthyl group included in a cavity of a cyclodextrin. 2. The cyclodextrin-bonded indocyanine cation of claim 1 , which has the formula (15) or (16). 3. The cyclodextrin-bonded indocyanine cation of claim 1 , which has the formula (19) or (20). 4. A composition, comprising: the cyclodextrin-bonded indocyanine cation of claim 1 . 5. The composition of claim 4 , further comprising: water. 6. The composition of claim 5 , wherein the cyclodextrin-bonded indocyanine cation has the formula (15) or (16). 7. The composition of claim 5 , wherein the cyclodextrin-bonded indocyanine cation has the formula (19) or (20). 8. The composition of claim 4 , which is in a form capable of being dissolved in water to provide an aqueous solution. 9. The composition of claim 8 , wherein the cyclodextrin-bonded indocyanine cation has the formula (15) or (16). 10. The composition of claim 8 , wherein the cyclodextrin-bonded indocyanine cation has the formula (19) or (20). 11. A solid cyclodextrin-bonded indocyanine of formula (16) or (20): wherein in the formulas (16) and (20), the indocyanine structure has at least a portion of a naphthyl group included in a cavity of a cyclodextrin. 12. The solid cyclodextrin-bonded indocyanine of claim 11 , which has the formula (20). 13. The solid cyclodextrin-bonded indocyanine of claim 12 , which has an ESI-MS m/z [M] value corresponding to a molecular formula C 135 H 197 N 4 O 73 . 14. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by a method including mixing a compound of formula (18) with a compound of formula (14) in a medium to obtain a mixture: mixing a dehydration-condensing agent with the mixture to perform a dehydration-condensation reaction of the mixture, and optionally performing an inclusion reaction in water. 15. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by purification through column chromatography and elution with a medium including an acid selected from the group consisting of hydrochloric acid, trifluoroacetic acid, acetic acid, sulfuric acid, nitric acid and formic acid. 16. The solid cyclodextrin-bonded indocyanine of claim 12 , which is produced by purification through column chromatography and elution with a medium including hydrochloric acid. 17. The solid cyclodextrin-bonded indocyanine of claim 11 , which has the formula (16). 18. The solid cyclodextrin-bonded indocyanine of claim 17 , which has a ESI-MS m/z [M] + value corresponding to a molecular formula C 131 H 191 N 4 O 72 . 19. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by a method including mixing a compound of formula (13) with a compound of formula (14) in a medium to obtain a mixture: mixing a dehydration-condensing agent with the mixture to perform a dehydration-condensation reaction of the mixture, and optionally performing an inclusion reaction in water. 20. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by purification through column chromatography and elution with a medium including an acid selected from the group consisting of hydrochloric acid, trifluoroacetic acid, acetic acid, sulfuric acid, nitric acid and formic acid. 21. The solid cyclodextrin-bonded indocyanine of claim 17 , which is produced by purification through column chromatography and elution with a medium including hydrochloric acid. 22. A composition, comprising: the solid cyclodextrin-bonded indocyanine of claim 11 . 23. The composition of claim 22 , wherein the solid cyclodextrin-bonded indocyanine has the formula (20). 24. The composition of claim 22 , wherein the solid cyclodextrin-bonded indocyanine has the formula (16).

Assignees

Inventors

Classifications

  • Fluorescence in vivo · CPC title

  • lymph vessels, ducts or nodes · CPC title

  • more than five >CH- groups · CPC title

  • by measuring fluorescence emission · CPC title

  • Substituted non-aromatic cyclic groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10086090B2 cover?
The present invention aims at providing a novel indocyanine compound solving problems of conventionally used indocyanine green, such as solubility in water or physiological saline, a synthesis method and a purification method thereof, and a diagnostic composition including the novel indocyanine compound. Further, provided are a method for evaluating biokinetics of the novel indocyanine compound…
Who is the assignee on this patent?
National Univ Corporation Mie Univ, Univ Nagoya Nat Univ Corp, National Univ Corporaton Nagoya Univ
What technology area does this patent fall under?
Primary CPC classification A61K49/0054. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).